Though VEGF is the primary stimulant for tumor angiogenesis, IL-1β can also stimulate in vitro endothelial cell migration and proliferation [41] and angiogenesis in mouse models of cancer via up regulation of VEGFR2 [42], [43]. The gene discussed is KDR; the disease is cancer.